HHS Nominee Price Sidesteps Medicare Drug Pricing Negotiation Questions

Confirmation hearing for Rep. Tom Price centers on Obamacare repeal, but also addresses whether he would be aligned with President-elect Donald Trump in supporting government negotiation on drug prices.

HHS Secretary-designee Rep. Tom Price, R-Ga., avoided a definite position on whether he supports direct HHS negotiations for drug prices in Medicare during a hearing on his nomination by the Senate Health, Education, Labor and Pensions Committee Jan. 18.

The fact that he didn’t embrace the idea was not surprising but could still be viewed as a positive for...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access